Platelets are essential in medicine, regenerative therapies, and are an exceptionally effective cell culture reagent. But today, all platelets come from human donors. This creates limits in cost, scale, and access worldwide.

Plasma Bioworks grows human platelets at scale — no donors required.

Our technology serves both scientific and medical applications, from cell therapy and biomanufacturing to research and even longevity. We want to provide a consistent, ethical alternative to donor platelets and fetal serum.

Plasma bioworks began as a response to a problem we experienced firsthand: the high cost and ethical limits of donor-based materials in research. We saw an opportunity for a better way and built the platform to deliver it.

We’re a team of scientists and engineers with deep experience in synthetic biology and bioprocessing, united by a belief that science should be accessible, scalable, and resilient.